Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.770
-0.090 (-1.85%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tenax Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tenax Therapeutics stock have an average target of 20.67, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 333.33% from the current stock price of 4.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TENX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +235.43% | Oct 24, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +235.43% | Oct 14, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 30, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +528.93% | Feb 20, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +9,962.89% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.89
from -31.04
EPS Next Year
-5.27
from -6.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -6.31 | -0.93 | -1.09 | ||
| Avg | -6.89 | -5.27 | -4.19 | ||
| Low | -7.20 | -8.16 | -8.87 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.